Compare AbCellera Biologics Inc (ABCL) vs Fox Corp Class A (FOXA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Fox Corp Class A — how do they compare? AbCellera Biologics Inc trades at $7.19 (market cap $2.35B), while Fox Corp Class A trades at $53.39 (market cap $21.80B). The key difference: Fox Corp Class A is far larger — about 9.3× AbCellera Biologics Inc's market cap, and Fox Corp Class A pays a 1.02% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | FOXA | |
|---|---|---|
Market Cap | $2.35B | $21.80B |
Sector | Health | Media |
52-Week High | $8.12 | $76.11 |
52-Week Low | $2.78 | $48.79 |
Enterprise Value | $1.99B | $25.77B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 2.29% on the day, with strong analyst support (82% buy ratings) and a $9.67 consensus price target suggesting 26% upside. The stock shows bullish technical momentum with moving averages supporting the trend, though RSI levels indicate potential overbought conditions. Recent positive developments include a major $876 million collaboration with Jazz Pharmaceuticals and board expansions, offsetting concerns about negative cash flow and profitability metrics.
While ABCL faces significant fundamental challenges with negative margins and cash burn, the company's strong cash position ($626M) and recent strategic partnerships provide runway for growth. The primary investment thesis hinges on successful pipeline development and platform monetization, with risks centered on execution and path to profitability. Wall Street remains optimistic about the long-term platform value despite near-term financial headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →
